Golimumab

Details

Files

Generic Name:

Golimumab

Project Status:

Complete

Therapeutic Area:

Ulcerative colitis

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

July 12, 2013

Brand Name:

Simponi

Project Line:

Reimbursement Review

Project Number:

SR0341-000

Call for patient/clinician input closed:

August 2, 2013

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Ulcerative colitis

Recommendation Type:

Do not list at the submitted price

Final Recommendation:

March 19, 2014

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 12, 2013